StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3040
This month
7
This year
1432
Publishing Date
2023 - 11 - 14
9
2023 - 10 - 27
15
2023 - 08 - 10
9
2023 - 08 - 03
9
2023 - 07 - 28
10
2023 - 07 - 20
9
2023 - 06 - 02
9
2023 - 05 - 17
10
2023 - 05 - 10
9
2023 - 05 - 04
11
2023 - 05 - 03
92
2023 - 05 - 02
74
2023 - 05 - 01
92
2023 - 04 - 28
21
2023 - 04 - 27
15
2023 - 04 - 20
9
2023 - 03 - 13
18
2023 - 02 - 24
9
2023 - 02 - 23
12
2023 - 02 - 21
9
2023 - 01 - 25
10
2023 - 01 - 09
14
2022 - 12 - 08
9
2022 - 10 - 14
11
2022 - 10 - 06
10
2022 - 09 - 28
9
2022 - 09 - 26
10
2022 - 09 - 15
10
2022 - 09 - 05
10
2022 - 08 - 08
9
2022 - 08 - 03
11
2022 - 07 - 28
10
2022 - 07 - 25
9
2022 - 07 - 13
9
2022 - 07 - 12
10
2022 - 06 - 28
9
2022 - 06 - 24
9
2022 - 06 - 20
9
2022 - 05 - 17
9
2022 - 05 - 09
10
2022 - 03 - 30
8
2022 - 03 - 29
9
2022 - 03 - 16
11
2022 - 03 - 15
8
2022 - 03 - 01
9
2022 - 02 - 23
8
2022 - 02 - 18
10
2022 - 02 - 04
8
2022 - 02 - 01
8
2022 - 01 - 07
11
2021 - 12 - 14
9
2021 - 11 - 22
9
2021 - 11 - 09
8
2021 - 11 - 08
9
2021 - 11 - 04
8
2021 - 10 - 28
9
2021 - 10 - 27
8
2021 - 10 - 26
9
2021 - 09 - 28
8
2021 - 09 - 27
8
Sector
Commercial services
34
Communications
46
Construction
1
Consumer durables
16
Consumer non-durables
51
Consumer services
5
Distribution services
8
Educational services
1
Electronic technology
18
Energy minerals
3
Finance
70
Finance and insurance
10
Health care and social assistance
5
Health services
19
Health technology
3040
Industrial services
2
Information
2
Manufacturing
182
Mining, quarrying, and oil and gas extraction
1
Miscellaneous
7
N/a
209
Non-energy minerals
2
Process industries
17
Producer manufacturing
14
Professional, scientific, and technical services
22
Retail trade
9
Technology services
30
Transportation
1
Utilities
1
Wholesale trade
3
Tags
Acquisition
80
Alliances
67
America
48
Antibody
40
Application
33
Approval
52
Biopharma
44
Biotech
48
Biotechnology
81
Business
68
Cancer
130
Children
56
Clinical-trials-phase-ii
38
Clinical-trials-phase-iii
64
Collaboration
69
Companies
53
Conference
38
Covid
43
Covid-19
74
Deal
48
Diabetes
37
Disease
113
Drug
143
Dupixent
93
Earnings
64
Europe
67
Events
44
Expected
39
Fda
145
Financial
135
Genetown
52
Global
282
Growing
44
Growth
229
Health
59
Insulin
37
Market
567
Money
52
N/a
1892
News
80
People
148
Pharm-country
41
Pharma
126
Pharmaceutical
96
Positive
72
Potential
46
Report
238
Research
202
Results
260
Sanofi
160
Spac
46
Study
71
Technology
36
Therapeutics
260
Therapy
68
Treatment
183
Trial
103
Update
79
Vaccine
155
Year
35
Entities
Abbott laboratories
139
Abbvie inc.
131
Alnylam pharmaceuticals, inc.
58
Amgen inc.
106
Astellas pharma inc
52
Astrazeneca plc
145
Bausch health companies inc.
22
Baxter international inc.
35
Becton, dickinson and company
24
Biogen inc.
36
Biomarin pharmaceutical inc.
16
Biontech se
124
Boston scientific corporation
18
Bristol-myers squibb company
57
Byline bancorp, inc.
26
Csl ltd
19
Denali therapeutics inc.
15
Eli lilly and company
208
Endo international plc
17
Gilead sciences, inc.
28
Glaxosmithkline plc
241
Igm biosciences, inc.
30
Incyte corporation
87
Innate pharma s.a.
65
Innate pharma sa
66
Insulet corporation
13
Intellia therapeutics, inc.
11
Ionis pharmaceuticals, inc.
10
Johnson & johnson
310
Kadmon holdings, inc.
10
Kymera therapeutics, inc.
17
Ligand pharmaceuticals inc
11
Ligand pharmaceuticals incorporated
12
Mallinckrodt plc
10
Medtronic plc
30
Mobiv acquisition corp
65
Moderna, inc.
19
Morgan stanley
13
Mylan n.v.
26
Novartis ag
241
Novo nordisk a/s
93
Nurix therapeutics, inc.
10
Orange
45
Pegasus digital mobility acquisition corp.
17
Perrigo company
50
Pfizer, inc.
89
Provention bio, inc.
285
Rcf acquisition corp.
83
Reckitt benckiser group plc
16
Regeneron pharmaceuticals, inc.
165
Ricebran technologies
11
Sanofi
3040
Seagen inc.
11
Takeda pharmaceutical company limited
44
Terumo corp
10
Teva pharmaceutical industries limited
16
Teva pharmaceutical industries ltd
198
Thermo fisher scientific inc
26
Viatris inc.
69
Vir biotechnology, inc.
11
Symbols
AAPL
1091
ABB
1301
ABBV
908
ABLZF
1041
ABT
1543
AMGN
694
ARVL
3798
AZN
587
BDX
722
BMY
597
BNPQF
1628
BNPQY
1628
BNPZY
1627
CNY
2011
CSCO
808
DHR
724
ERIC
1459
EXTR
581
FNCTF
6070
GE
851
GLAXF
604
GOOG
1094
GOOGL
1094
GSK
824
HON
1612
HUBS
1290
IBM
604
INR
2014
INTC
874
JNJ
3972
LLY
1546
LTUM
869
LYV
717
MDT
1192
MLPY
2012
MMM
868
MS
3637
MS-PE
1440
MSFT
1126
NOK
824
NOKBF
884
NVO
566
NVS
1108
NVSEF
901
ORCL
1080
PCRFF
590
PCRFY
590
PFE
642
PHG
884
PPRUF
1004
PPRUY
1005
SAP
1397
SAPGF
1131
SNOW
705
SNY
3985
SNYNF
3040
TMO
1427
TOT
1591
URR
2010
VZ
1056
Exchanges
Amex
11
Lse
1
Nasdaq
3040
Nyse
1053
Crawled Date
2023 - 11 - 14
9
2023 - 10 - 27
15
2023 - 08 - 10
10
2023 - 08 - 03
9
2023 - 07 - 28
10
2023 - 07 - 20
9
2023 - 05 - 18
9
2023 - 05 - 17
9
2023 - 05 - 10
9
2023 - 05 - 04
12
2023 - 05 - 03
93
2023 - 05 - 02
75
2023 - 05 - 01
92
2023 - 04 - 28
25
2023 - 04 - 27
11
2023 - 04 - 20
9
2023 - 03 - 13
18
2023 - 02 - 24
9
2023 - 02 - 23
13
2023 - 01 - 25
10
2023 - 01 - 09
13
2022 - 12 - 15
9
2022 - 12 - 08
9
2022 - 10 - 14
11
2022 - 10 - 07
9
2022 - 10 - 06
9
2022 - 09 - 28
9
2022 - 09 - 26
10
2022 - 09 - 15
10
2022 - 09 - 05
11
2022 - 08 - 08
9
2022 - 08 - 03
11
2022 - 07 - 28
10
2022 - 07 - 25
9
2022 - 07 - 13
9
2022 - 07 - 12
10
2022 - 06 - 28
9
2022 - 06 - 24
9
2022 - 06 - 20
9
2022 - 05 - 17
9
2022 - 05 - 09
10
2022 - 03 - 30
8
2022 - 03 - 29
9
2022 - 03 - 22
8
2022 - 03 - 16
11
2022 - 03 - 15
8
2022 - 03 - 01
9
2022 - 02 - 23
9
2022 - 02 - 18
10
2022 - 02 - 01
8
2022 - 01 - 07
11
2021 - 12 - 14
8
2021 - 11 - 22
9
2021 - 11 - 09
8
2021 - 11 - 08
9
2021 - 10 - 28
9
2021 - 10 - 27
8
2021 - 10 - 26
9
2021 - 09 - 28
8
2021 - 09 - 27
8
Crawled Time
00:00
74
00:20
17
01:00
70
02:00
36
03:00
24
04:00
19
04:20
6
05:00
49
06:00
87
07:00
99
08:00
79
08:20
4
09:00
72
10:00
81
11:00
199
12:00
223
12:15
9
12:20
70
12:30
28
13:00
192
13:15
8
13:20
59
13:30
40
14:00
166
14:15
12
14:20
48
14:30
30
15:00
124
15:15
6
15:20
50
15:30
38
16:00
164
16:20
22
17:00
145
18:00
122
19:00
108
20:00
104
20:20
15
21:00
148
22:00
107
23:00
86
Source
contravir.com
1
investors.biomarin.com
7
investors.phiopharma.com
1
ir.biolinerx.com
1
ir.voyagertherapeutics.com
2
ir.vtvtherapeutics.com
1
nutriband.com
1
purple-biotech.com
1
spacfeed.com
279
thehackettgroup.com
1
www.agtc.com
1
www.algernonpharmaceuticals.com
2
www.alnylam.com
1
www.baldwinriskpartners.com
1
www.biospace.com
1148
www.capgemini.com
1
www.clarivate.com
4
www.curevac.com
1
www.everbridge.com
1
www.globenewswire.com
460
www.inovio.com
2
www.interpublic.com
2
www.invobioscience.com
1
www.jupiterwellnessinc.com
2
www.modeln.com
23
www.nurixtx.com
1
www.oncocyte.com
1
www.precisionbiosciences.com
2
www.prnewswire.com
1089
www.snowflake.com
1
www.vbivaccines.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Snynf
save search
The Rockefeller Foundation Commits USD 100 Million to Test and Scale Climate and Health Solutions Globally
Published:
2023-12-02
(Crawled : 12:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
test
health
solutions
100
41 Funders, Partners Endorse New Guiding Principles for Financing Climate and Health Solutions to Protect Health
Published:
2023-12-02
(Crawled : 12:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
health
solutions
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 23:00)
- prnewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$8.5
5.21%
100
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
G
|
$272.45
1.04%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
companies
astrazeneca
cancer
therapeutics
market
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$234.64
0.24%
1.86%
730K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
|
$0.26
-6.81%
1.88%
3.8M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$9.37
2.07%
0.0%
7.4M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster S...
Published:
2023-12-01
(Crawled : 14:30)
- biospace.com/
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
0.93%
|
O:
0.93%
H:
0.0%
C:
0.0%
vaccine
rsv
market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
Published:
2023-12-01
(Crawled : 13:30)
- biospace.com/
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
0.93%
|
O:
0.93%
H:
0.0%
C:
0.0%
vaccine
rsv
market
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023
Published:
2023-12-01
(Crawled : 06:00)
- biospace.com/
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
0.93%
|
O:
0.93%
H:
0.0%
C:
0.0%
INCY
|
$54.02
-0.59%
1.07%
1.9M
|
Health Technology
|
-0.17%
|
O:
-0.17%
H:
0.0%
C:
0.0%
ibi351
lung
congress
update
cancer
asia
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-0.35%
|
O:
-0.35%
H:
0.0%
C:
0.0%
TEVA
|
$9.71
-1.12%
0.0%
6.6M
|
Health Technology
|
1.34%
|
O:
-0.52%
H:
3.73%
C:
1.87%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-0.17%
|
O:
-1.09%
H:
0.0%
C:
0.0%
disease
treatment
collaboration
teva
deal
Metastatic HER2-Positive Breast Cancer Market to Grow by 2032 at a 5.2% CAGR | DelveInsight
Published:
2023-11-29
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-0.35%
|
O:
-0.35%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-0.17%
|
O:
-1.09%
H:
0.0%
C:
0.0%
IMMP
|
$1.99
1.01%
83K
|
Health Technology
|
6.99%
|
O:
6.45%
H:
1.52%
C:
0.51%
breast
cancer
market
Deals, Dupixent and GLP-1 drug shortages
Published:
2023-11-29
(Crawled : 15:30)
- biospace.com/
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-0.98%
|
O:
-0.15%
H:
0.07%
C:
-0.66%
drug
dupixent
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
Published:
2023-11-28
(Crawled : 22:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
LLY
2 d
|
$584.04
-1.18%
0.34%
3.6M
|
Health Technology
|
0.37%
|
O:
-0.06%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-0.98%
|
O:
-0.15%
H:
0.07%
C:
-0.66%
BPMC
|
$72.05
3.46%
0.0%
820K
|
Health Technology
|
1.86%
|
O:
0.5%
H:
1.86%
C:
-0.33%
lung
biomarker
cancer
cell
market
FDA Decisions: First Treatment for Desmoid Tumors and a Dry Eye Rejection for Aldeyra
Published:
2023-11-28
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-2.21%
|
O:
-1.89%
H:
0.02%
C:
0.02%
PRGO
P
|
$30.9
1.44%
0.0%
1.3M
|
Health Technology
|
-1.33%
|
O:
0.78%
H:
0.81%
C:
-1.71%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.44%
|
O:
0.09%
H:
0.0%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
1.47%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-2.37%
|
O:
-1.41%
H:
0.87%
C:
0.0%
fda
tumors
treatment
eye
Vaxcyte Appoints Jacks Lee to Board of Directors
Published:
2023-11-28
(Crawled : 14:00)
- globenewswire.com
PPRUF
|
$426.544
-2.5%
44.35%
1.5K
|
Consumer Non-Durables
|
-4.3%
|
O:
-1.83%
H:
1.83%
C:
-2.33%
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-2.21%
|
O:
-1.89%
H:
0.02%
C:
0.02%
PCVX
S
|
$53.81
3.94%
0.0%
600K
|
Health Technology
|
3.27%
|
O:
-1.82%
H:
1.91%
C:
1.75%
STRO
|
$2.75
5.36%
0.73%
1M
|
Health Technology
|
1.32%
|
O:
6.14%
H:
1.24%
C:
-5.79%
GTHX
|
$2.0
6.38%
-2.5%
1.1M
|
Health Technology
|
12.2%
|
O:
-1.83%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-2.37%
|
O:
-1.41%
H:
0.87%
C:
0.0%
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published:
2023-11-27
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-2.21%
|
O:
-1.89%
H:
0.02%
C:
0.02%
VTRS
|
$9.37
2.07%
0.0%
7.4M
|
Health Technology
|
-2.56%
|
O:
-0.64%
H:
0.21%
C:
-1.93%
TAK
|
$14.17
0.14%
0.0%
830K
|
Health Technology
|
0.57%
|
O:
-0.07%
H:
0.28%
C:
0.21%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
1.47%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
VNDA
|
$3.9
4.84%
2.56%
890K
|
Health Technology
|
4.49%
|
O:
2.81%
H:
0.0%
C:
-3.01%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-2.37%
|
O:
-1.41%
H:
0.87%
C:
0.0%
america
therapeutics
growth
market
Regeneron and Sanofi Find Further Positive Results for Dupixent in COPD
Published:
2023-11-27
(Crawled : 17:00)
- biospace.com/
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
dupixent
positive
copd
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.44
1.67%
0.0%
12K
|
Health Technology
|
-0.83%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease
Published:
2023-11-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
REGN
|
$814.86
-1.09%
0.31%
560K
|
Health Technology
|
3.06%
|
O:
-0.03%
H:
0.37%
C:
-0.49%
dupixent
fda
disease
approved
positive
copd
potential
submission
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Published:
2023-11-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
REGN
|
$814.86
-1.09%
0.31%
560K
|
Health Technology
|
3.06%
|
O:
-0.03%
H:
0.37%
C:
-0.49%
dupixent
fda
disease
approved
positive
copd
potential
submission
Biotech Breakthrough
Published:
2023-11-26
(Crawled : 00:00)
- spacfeed.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
biotech
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published:
2023-11-25
(Crawled : 08:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
ELAN
|
$12.4
5.26%
0.08%
6.6M
|
Process Industries
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
ZTS
|
$179.13
1.39%
0.49%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
$12.36
0.08%
-26.03%
1K
|
Communications
|
Email alert
Add to watchlist
vaccine
reach
research
market
← Previous
1
2
3
4
5
6
7
8
9
…
151
152
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
BKKT
4
|
$1.88
25.33%
14.89%
4.8M
|
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
SAIC
4
|
$119.92
2.14%
4.24%
460K
|
Technology Services
LGL
4
|
$4.94
1.23%
3.04%
15K
|
Electronic Technology
TELL
|
$0.65
6.73%
2.99%
41M
|
Energy Minerals
CVNA
4
|
$35.2
12.39%
2.84%
12M
|
Retail Trade
SOS
|
$4.0
6.1%
2.5%
130K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.